C186H199F15N30O27S — CID 159801934
2-(1,1-difluoroethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;3-(difluoromethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]benzamide;2-(1,1-difluoropropyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-3-methylsulfonylbenzamide;N-[5-[6-[(3S,4S)-3-methoxyoxan-4-yl]oxy-5-morpholin-4-yl-3-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide;1-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]-2-[3-(trifluoromethyl)phenyl]ethanone (PubChem CID 159801934) has the molecular formula C186H199F15N30O27S and a molecular weight of 3603.86 g/mol. Its IUPAC name is 2-(1,1-difluoroethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;3-(difluoromethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]benzamide;2-(1,1-difluoropropyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-3-methylsulfonylbenzamide;N-[5-[6-[(3S,4S)-3-methoxyoxan-4-yl]oxy-5-morpholin-4-yl-3-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide;1-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]-2-[3-(trifluoromethyl)phenyl]ethanone.
| Compound Name | 2-(1,1-difluoroethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;3-(difluoromethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]benzamide;2-(1,1-difluoropropyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-3-methylsulfonylbenzamide;N-[5-[6-[(3S,4S)-3-methoxyoxan-4-yl]oxy-5-morpholin-4-yl-3-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide;1-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]-2-[3-(trifluoromethyl)phenyl]ethanone |
|---|---|
| PubChem CID | 159801934 |
| Molecular Formula | C186H199F15N30O27S |
| Molecular Weight | 3603.86 g/mol |
| Exact Mass | 3601.46 |
| IUPAC Name | 2-(1,1-difluoroethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;3-(difluoromethyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]benzamide;2-(1,1-difluoropropyl)-N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]pyridine-4-carboxamide;N-[3-(6-ethoxy-5-morpholin-4-ylpyridazin-3-yl)-4-methylphenyl]-3-methylsulfonylbenzamide;N-[5-[6-[(3S,4S)-3-methoxyoxan-4-yl]oxy-5-morpholin-4-yl-3-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[4-methyl-3-[2-morpholin-4-yl-6-(oxan-4-yloxy)-4-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide;1-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]-2-[3-(trifluoromethyl)phenyl]ethanone |
| SMILES | CCOc1nnc(-c2cc(NC(=O)c3cccc(C(F)F)c3)ccc2C)cc1N1CCOCC1.CCOc1nnc(-c2cc(NC(=O)c3cccc(S(C)(=O)=O)c3)ccc2C)cc1N1CCOCC1.CCOc1nnc(-c2cc(NC(=O)c3ccnc(C(C)(F)F)c3)ccc2C)cc1N1CCOCC1.CCOc1nnc(-c2cc(NC(=O)c3ccnc(C(F)(F)CC)c3)ccc2C)cc1N1CCOCC1.CO[C@H]1COCC[C@@H]1Oc1ncc(-c2cc(NC(=O)c3cccc(C(F)(F)F)c3)cnc2C)cc1N1CCOCC1.Cc1ccc(NC(=O)c2cnnc(C(F)(F)F)c2)cc1-c1cc(OC2CCOCC2)nc(N2CCOCC2)c1.Cc1ncc(C(=O)Cc2cccc(C(F)(F)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1 |
| InChI | InChI=1S/C29H31F3N4O5.C29H30F3N3O4.C27H28F3N5O4.C26H29F2N5O3.C25H27F2N5O3.C25H26F2N4O3.C25H28N4O5S/c1-18-23(14-22(16-33-18)35-27(37)19-4-3-5-21(12-19)29(30,31)32)20-13-24(36-7-10-39-11-8-36)28(34-15-20)41-25-6-9-40-17-26(25)38-2;1-19-25(15-22(18-33-19)27(36)14-20-3-2-4-23(13-20)29(30,31)32)21-16-26(35-7-11-38-12-8-35)28(34-17-21)39-24-5-9-37-10-6-24;1-17-2-3-20(32-26(36)19-12-23(27(28,29)30)34-31-16-19)15-22(17)18-13-24(35-6-10-38-11-7-35)33-25(14-18)39-21-4-8-37-9-5-21;1-4-26(27,28)23-14-18(8-9-29-23)24(34)30-19-7-6-17(3)20(15-19)21-16-22(25(32-31-21)36-5-2)33-10-12-35-13-11-33;1-4-35-24-21(32-9-11-34-12-10-32)15-20(30-31-24)19-14-18(6-5-16(19)2)29-23(33)17-7-8-28-22(13-17)25(3,26)27;1-3-34-25-22(31-9-11-33-12-10-31)15-21(29-30-25)20-14-19(8-7-16(20)2)28-24(32)18-6-4-5-17(13-18)23(26)27;1-4-34-25-23(29-10-12-33-13-11-29)16-22(27-28-25)21-15-19(9-8-17(21)2)26-24(30)18-6-5-7-20(14-18)35(3,31)32/h3-5,12-16,25-26H,6-11,17H2,1-2H3,(H,35,37);2-4,13,15-18,24H,5-12,14H2,1H3;2-3,12-16,21H,4-11H2,1H3,(H,32,36);6-9,14-16H,4-5,10-13H2,1-3H3,(H,30,34);5-8,13-15H,4,9-12H2,1-3H3,(H,29,33);4-8,13-15,23H,3,9-12H2,1-2H3,(H,28,32);5-9,14-16H,4,10-13H2,1-3H3,(H,26,30)/t25-,26-;;;;;;/m0....../s1 |
| InChIKey | NJXFDCUCDGXKKQ-LNZVLMDESA-N |
| XLogP | 32.05 |
| TPSA | 633.76 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 51 |
| Rotatable Bonds | 49 |
| Heavy Atoms | 259 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3603.86 |
| LogP ≤ 5 | 32.05 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 51 |